Donald J. Santel's most recent trade in Jade Biosciences Inc was a trade of 12,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 5, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Jade Biosciences Inc | Donald J. Santel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Donald Santel J. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 2,889 | 2,889 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Donald J. Santel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Donald J. Santel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2023 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Donald J. Santel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2023 | 2,519 | 2,519 | - | - | Stock Option (Right to Buy) |